Home > Analytics > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Intrinsic Value | Fundamental Analysis

BOM : 532531     NSE : STAR    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : High [>50%]
Oct 10,2024
Price(EOD): ₹ 1,516.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 13,950.88 Cr
Value of ₹ 1 Lac invested in STRIDES PHARMA SCIENCE
on Oct 10,2019 (price: ₹ 316.85)

₹ 1 L

₹ 4.79 L

1W : 4.3% 1M : 12.2% 1Y : 200.9%
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
STRIDES PHARMA SCIENCE 4.3% 12.2% 200.9%
SUN PHARMACEUTICAL INDUSTRIES -1.2% 2.8% 71.4%
CIPLA -0.3% -0.8% 44.6%
DR REDDYS LABORATORIES -0.8% -1% 23%
ZYDUS LIFESCIENCES -0% -5% 76.5%
DIVIS LABORATORIES 9.6% 9.4% 60.9%

FUNDAMENTAL ANALYSIS OF STRIDES PHARMA SCIENCE

 
Fundamentals Score
[ Q(TTM): Jun2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF STRIDES PHARMA SCIENCE

 
Valuation Score
[As on : Oct 10,2024 ]

Ratio Consolidated
P/E
P/B
P/S
166.5
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 83.75 Cr
[Latest Qtr - Jun2024 - Consolidated Results ]

6.57
P/B Calculated based on Book Value of Rs 2,122.47 Cr
[Latest Year - Mar2024 - Consolidated Results ]

3.31
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,208.63 Cr
[Latest Qtr - Jun2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF STRIDES PHARMA SCIENCE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
766%
29%
46%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF STRIDES PHARMA SCIENCE


Insights 💡 STAR is one of the top 23% companies with bullish price momentum currently! Discover More →

STRIDES PHARMA SCIENCE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF STRIDES PHARMA SCIENCE

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.45
0.39
0.37
0.4
1.14
1.27
1.18
1.2
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF STRIDES PHARMA SCIENCE

Pledged Promoter Shares
69.17 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF STRIDES PHARMA SCIENCE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.32%
-5.55%
24.01%
35.91%
16.94%
30.25%
191.68%
239.92%
QtrlyTrend
6
Latest Qtr: Jun2024
Quarterly Result Analysis →


STRIDES PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 0.7% 1.6% 57.8%
S&P BSE SMALL CAP -0.1% 1.3% 49.7%
S&P BSE MIDSMALLCAP -0.2% 0.6% 50.5%
S&P BSE ALLCAP -0.6% 0.3% 37.5%
No NSE index found

You may also like the below Video Courses


FAQ about STRIDES PHARMA SCIENCE


Is STRIDES PHARMA SCIENCE good for long term investment?

As on Oct 10,2024, the Fundamentals of STRIDES PHARMA SCIENCE look Poor and hence it may not be good for long term investment ! See Financial Performance of STRIDES PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is STRIDES PHARMA SCIENCE UnderValued or OverValued?

As on Oct 10,2024, STRIDES PHARMA SCIENCE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of STRIDES PHARMA SCIENCE ?

As on Oct 10,2024, the Intrinsic Value of STRIDES PHARMA SCIENCE is Rs. 1,037.45 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 175.18
Fair Value [Median EV / Sales Model] : Rs. 1,179.12
Fair Value [Median Price / Sales Model] : Rs. 1,037.45
Estimated Median Fair Value of STRIDES PHARMA SCIENCE : Rs. 1,037.45

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is STRIDES PHARMA SCIENCE trading at a Premium or Discount?

As on Oct 10,2024, STRIDES PHARMA SCIENCE is trading at a Premium of 46% based on the estimates of Median Intrinsic Value!